Correlation between CEUS LI-RADS categorization of HCC < 20 mm and clinic-pathological features
View abstract on PubMed
Summary
This summary is machine-generated.Contrast-enhanced ultrasound (CEUS) LI-RADS is valuable for diagnosing small liver nodules (<20mm) suspicious for hepatocellular carcinoma (HCC). Combining CEUS LI-RADS with clinic-pathological features improves diagnostic accuracy for HCC.
Area Of Science
- Radiology
- Hepatology
- Oncology
Background
- Small liver nodules (<20mm) pose diagnostic challenges for hepatocellular carcinoma (HCC).
- Contrast-enhanced ultrasound (CEUS) with LI-RADS (Liver Imaging Reporting and Data System) is used for HCC assessment.
- Accurate characterization of small nodules is crucial for timely treatment and improved patient outcomes.
Purpose Of The Study
- To evaluate the diagnostic performance of CEUS LI-RADS for liver nodules <20mm at high risk for HCC.
- To assess the correlation between CEUS LI-RADS categories and clinic-pathological features.
- To determine if combining clinic-pathological data improves diagnostic accuracy.
Main Methods
- Retrospective analysis of 432 pathologically proven liver nodules <20mm.
- Nodules categorized using CEUS LI-RADS (LR-1 to LR-5, LR-M).
- Evaluation of sensitivity, specificity, PPV, NPV, and AUC against pathological standards; correlation with clinic-pathological features.
Main Results
- CEUS LI-RADS LR-5 showed 50.3% sensitivity and 70.0% specificity for HCC.
- Combining clinic-pathological features and imaging criteria (e.g., APHE, washout) improved LR-5 performance (sensitivity 60.2%, AUC 0.651).
- Nodule size, HCC history, and differentiation grade influenced CEUS LI-RADS categorization and features.
Conclusions
- CEUS LI-RADS is a valuable tool for diagnosing small HCC (<20mm).
- Integrating clinic-pathological features with CEUS LI-RADS enhances diagnostic performance.
- Further research is warranted to refine its utility in this specific nodule size range.

